Mei Xue

2.6k total citations · 1 hit paper
89 papers, 1.8k citations indexed

About

Mei Xue is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, Mei Xue has authored 89 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 17 papers in Molecular Biology and 17 papers in Immunology. Recurrent topics in Mei Xue's work include Hematopoietic Stem Cell Transplantation (21 papers), Mesenchymal stem cell research (8 papers) and Acute Myeloid Leukemia Research (7 papers). Mei Xue is often cited by papers focused on Hematopoietic Stem Cell Transplantation (21 papers), Mesenchymal stem cell research (8 papers) and Acute Myeloid Leukemia Research (7 papers). Mei Xue collaborates with scholars based in China, United States and France. Mei Xue's co-authors include Jin‐Tai Yu, Ya‐Nan Ou, Lan Tan, Xi‐Peng Cao, Wei Xu, Meng‐Shan Tan, Luyong Zhang, Shuyu Yang, Zhenzhou Jiang and Xiu-Min Li and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Mei Xue

82 papers receiving 1.8k citations

Hit Papers

Diabetes mellitus and risks of cognitive impairment and d... 2019 2026 2021 2023 2019 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mei Xue China 21 484 270 233 233 188 89 1.8k
Valeria Conti Italy 29 715 1.5× 553 2.0× 185 0.8× 118 0.5× 261 1.4× 124 2.9k
A. Jyothy India 26 569 1.2× 136 0.5× 59 0.3× 210 0.9× 378 2.0× 135 2.2k
Hari M. Sharma United States 27 456 0.9× 228 0.8× 320 1.4× 70 0.3× 134 0.7× 95 2.3k
Hatîce Paşaoğlu Türkiye 26 347 0.7× 290 1.1× 69 0.3× 94 0.4× 308 1.6× 123 2.1k
Karina Braga Gomes Brazil 31 850 1.8× 580 2.1× 50 0.2× 319 1.4× 355 1.9× 194 3.8k
Susan Hart Australia 20 652 1.3× 203 0.8× 47 0.2× 114 0.5× 134 0.7× 53 2.4k
Hong Yan China 29 1.1k 2.4× 239 0.9× 75 0.3× 83 0.4× 158 0.8× 139 2.4k
P. H. Whiting United Kingdom 33 545 1.1× 524 1.9× 124 0.5× 101 0.4× 192 1.0× 122 3.0k
Asad Vaisi‐Raygani Iran 29 548 1.1× 325 1.2× 32 0.1× 228 1.0× 152 0.8× 157 2.5k

Countries citing papers authored by Mei Xue

Since Specialization
Citations

This map shows the geographic impact of Mei Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei Xue more than expected).

Fields of papers citing papers by Mei Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mei Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei Xue. The network helps show where Mei Xue may publish in the future.

Co-authorship network of co-authors of Mei Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Mei Xue. A scholar is included among the top collaborators of Mei Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mei Xue. Mei Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xue, Mei, Lingling Huang, Yueyong Zhu, & Qi Zheng. (2025). Case report: ZFYVE19 gene mutation is associated with familial cholestasis. Frontiers in Medicine. 11. 1400475–1400475. 1 indexed citations
2.
Li, Jiaqi, Yueyong Zhu, Mei Xue, et al.. (2025). Clinical features and long-term outcomes of patients with ZFYVE19 variants. Digestive and Liver Disease. 57(5). 1021–1027.
3.
Lu, Jie, Mei Xue, Yichen Wang, et al.. (2025). Sepsis impairs immunocompetent plasmacytoid dendritic cell reconstitution from hematopoietic stem/progenitor cell through altered bone marrow environment. The International Journal of Biochemistry & Cell Biology. 186. 106823–106823.
4.
Scott, Jeffrey A., Jochen K. Lennerz, Melissa L. Johnson, et al.. (2023). Compromised Outcomes in Stage IV Non–Small-Cell Lung Cancer With Actionable Mutations Initially Treated Without Tyrosine Kinase Inhibitors: A Retrospective Analysis of Real-World Data. JCO Oncology Practice. 20(1). 145–153. 28 indexed citations
5.
Xue, Mei, et al.. (2022). Quality Comparison of Glutinous Rice Fermented Wine and Waxy Maize Fermented Wine. SHILAP Revista de lepidopterología. 1 indexed citations
6.
Ding, Li, Dongmei Han, Hong-Min Yan, et al.. (2022). Infusion of haploidentical HSCs combined with allogenic MSCs for the treatment of ALL patients. Bone Marrow Transplantation. 57(7). 1086–1094. 4 indexed citations
7.
Gordan, Lucio, et al.. (2021). Daratumumab Utilization and Cost Analysis among Patients with Multiple Myeloma in a US Community Oncology Setting. Future Oncology. 18(3). 301–309. 5 indexed citations
8.
Li, Zezhi, Mei Xue, Lei Zhao, et al.. (2021). Comorbid major depression in first-episode drug-naïve patients with schizophrenia: Analysis of the Depression in Schizophrenia in China (DISC) study. Journal of Affective Disorders. 294. 33–38. 6 indexed citations
9.
Xiong, Bei, Mei Xue, Yalan Yu, Sanyun Wu, & Xuelan Zuo. (2020). SF3B1 Mutation but Not Ring Sideroblasts Identifies a Specific Group of Myelodysplastic Syndrome–Refractory Cytopenia With Multilineage Dysplasia. Clinical Lymphoma Myeloma & Leukemia. 20(5). 329–339.e3. 5 indexed citations
10.
Xue, Mei, Wei Xu, Ya‐Nan Ou, et al.. (2019). Diabetes mellitus and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 144 prospective studies. Ageing Research Reviews. 55. 100944–100944. 419 indexed citations breakdown →
11.
Shalaby, Lobna, et al.. (2019). Treatment of immunocompromised patients with suspected invasive fungal infections: economic analysis of diagnostic-driven versus empirical strategies in Algeria and Egypt. Expert Review of Pharmacoeconomics & Outcomes Research. 19(6). 693–700. 3 indexed citations
14.
Liu, Jing, Dongmei Han, Mei Xue, et al.. (2014). Intrathecal injection of umbilical cord mesenchymal stem cells for spinocerebellar ataxia. Zhongguo zuzhi gongcheng yanjiu yu linchuang kangfu. 18(41). 6666–6670. 1 indexed citations
15.
Li, Xiu-Min, Xiu-Min Li, Zhipeng Li, et al.. (2013). Fructus Xanthii Attenuates Hepatic Steatosis in Rats Fed on High-Fat Diet. PLoS ONE. 8(4). e61499–e61499. 12 indexed citations
16.
Xue, Mei, Yan Zhao, Xuejun Li, et al.. (2012). Comparison of toxicokinetic and tissue distribution of triptolide-loaded solid lipid nanoparticles vs free triptolide in rats. European Journal of Pharmaceutical Sciences. 47(4). 713–717. 52 indexed citations
17.
Xue, Mei, Zhenzhou Jiang, Ming Yan, et al.. (2012). Protective effects of tripterygium glycoside-loaded solid lipid nanoparticles on male reproductive toxicity in rats. Arzneimittelforschung. 61(10). 571–576. 9 indexed citations
18.
Xue, Mei, et al.. (2009). [Effect of the active components of red paeonia and rhizoma chuanxiong on matrix metalloproteinases in rabbits with atherosclerosis].. PubMed. 29(6). 514–8. 2 indexed citations
19.
Chen, Hong‐Ru, et al.. (2002). G-CSF-primed haploidentical marrow transplantation without ex vivo T cell depletion: an excellent alternative for high-risk leukemia. Bone Marrow Transplantation. 30(12). 861–866. 36 indexed citations
20.
Xue, Mei, et al.. (2001). [Study on Growth and Maturation of Megakaryocyte Progenitors In Vitro in Patients with Chronic Idiopathic Thrombocytopenic Purpura]. PubMed. 9(1). 52–55. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026